Leading medical societies and women’s health organizations released revised clinical guidelines for managing vasomotor menopause symptoms, providing updated advice regarding hormone replacement therapies and non-hormonal treatment alternatives. The updated clinical consensus document re-evaluates decades of longitudinal health data, clarifying that initiating hormone replacement therapy within ten years of menopause onset poses minimal cardiovascular risk for eligible candidates while providing substantial relief from debilitating hot flashes, sleep fragmentation, and bone density loss.
The revised recommendations also spotlight recently approved non-hormonal neurokinin 3 receptor antagonists, which directly target thermoregulatory neural pathways in the brain without altering systemic estrogen levels. Gynecologists highlighted that personalized risk-benefit evaluations must consider individual family histories of cardiovascular disease, breast cancer, and venous thromboembolism before selecting tailored medical regimens. Clinical educators emphasized that open patient-physician dialogue and transparent risk assessments ensure women navigate menopausal transitions with safe, evidence-based symptom management.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.thehindu.com/sci-tech/health/theres-new-guidance-on-menopause-symptoms-like-hot-flashes-what-women-need-to-know/article71652471.ece